SU841590A3 - Способ получени производных - -( -АМиНО- -ТиАзОлил)- - АлКОКСииМиНОАцЕТАМидО - -( - ТиАдиАзОл- -илТиОМЕТил)цЕф- -EM-- КАРбОНОВОй КиСлОТы или иХ СОлЕйС щЕлОчНыМи МЕТАллАМи, B ВидЕ СиН-изО-MEPOB - Google Patents
Способ получени производных - -( -АМиНО- -ТиАзОлил)- - АлКОКСииМиНОАцЕТАМидО - -( - ТиАдиАзОл- -илТиОМЕТил)цЕф- -EM-- КАРбОНОВОй КиСлОТы или иХ СОлЕйС щЕлОчНыМи МЕТАллАМи, B ВидЕ СиН-изО-MEPOB Download PDFInfo
- Publication number
- SU841590A3 SU841590A3 SU782578251A SU2578251A SU841590A3 SU 841590 A3 SU841590 A3 SU 841590A3 SU 782578251 A SU782578251 A SU 782578251A SU 2578251 A SU2578251 A SU 2578251A SU 841590 A3 SU841590 A3 SU 841590A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- product
- acid
- mixture
- syn
- amino
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims description 18
- 238000000034 method Methods 0.000 title claims description 6
- IKWLIQXIPRUIDU-ZCFIWIBFSA-N (6r)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCS[C@@H]2CC(=O)N12 IKWLIQXIPRUIDU-ZCFIWIBFSA-N 0.000 title 1
- 229910052751 metal Inorganic materials 0.000 title 1
- 239000002184 metal Substances 0.000 title 1
- 150000002739 metals Chemical class 0.000 title 1
- -1 amine cation Chemical class 0.000 claims abstract description 57
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 8
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 8
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000005903 acid hydrolysis reaction Methods 0.000 claims abstract description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 3
- 239000001257 hydrogen Substances 0.000 claims abstract 3
- 239000000047 product Substances 0.000 claims description 86
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 78
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 62
- 239000000203 mixture Substances 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 239000002253 acid Substances 0.000 claims description 32
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 20
- 159000000000 sodium salts Chemical class 0.000 claims description 18
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- 239000000377 silicon dioxide Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 150000008064 anhydrides Chemical class 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- FUWXWRNWTLNQGG-UHFFFAOYSA-N 3-methoxy-2h-1,2,4-thiadiazole-5-thione Chemical compound COC1=NC(=S)SN1 FUWXWRNWTLNQGG-UHFFFAOYSA-N 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 5
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 5
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 241000295644 Staphylococcaceae Species 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 4
- 238000000354 decomposition reaction Methods 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 238000010255 intramuscular injection Methods 0.000 claims description 4
- 239000007927 intramuscular injection Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 claims description 4
- 239000012264 purified product Substances 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- 239000008223 sterile water Substances 0.000 claims description 4
- LZTRCELOJRDYMQ-UHFFFAOYSA-N triphenylmethanol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)C1=CC=CC=C1 LZTRCELOJRDYMQ-UHFFFAOYSA-N 0.000 claims description 4
- 238000002211 ultraviolet spectrum Methods 0.000 claims description 4
- PKPGSMOHYWOGJR-UHFFFAOYSA-N 2-methoxyimino-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetic acid Chemical compound CON=C(C(O)=O)C1=CSC(NC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 PKPGSMOHYWOGJR-UHFFFAOYSA-N 0.000 claims description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- GYGNJEASCVSRLC-UHFFFAOYSA-N 5-chloro-3-methoxy-1,2,4-thiadiazole Chemical compound COC1=NSC(Cl)=N1 GYGNJEASCVSRLC-UHFFFAOYSA-N 0.000 claims description 2
- 241000192125 Firmicutes Species 0.000 claims description 2
- 241000588748 Klebsiella Species 0.000 claims description 2
- 229930182555 Penicillin Natural products 0.000 claims description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 2
- 241000607142 Salmonella Species 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 239000003708 ampul Substances 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 2
- 238000013375 chromatographic separation Methods 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000000921 elemental analysis Methods 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 claims description 2
- 239000007903 gelatin capsule Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 150000007529 inorganic bases Chemical class 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 239000012452 mother liquor Substances 0.000 claims description 2
- 150000007530 organic bases Chemical group 0.000 claims description 2
- 229940049954 penicillin Drugs 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 235000011056 potassium acetate Nutrition 0.000 claims description 2
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 210000000664 rectum Anatomy 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 239000012047 saturated solution Substances 0.000 claims description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 125000005270 trialkylamine group Chemical group 0.000 claims description 2
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 150000004678 hydrides Chemical class 0.000 claims 2
- 239000003791 organic solvent mixture Substances 0.000 claims 2
- ZAEUOCGSFKFWHY-UHFFFAOYSA-N 3-methoxy-1,2,4-thiadiazole Chemical compound COC=1N=CSN=1 ZAEUOCGSFKFWHY-UHFFFAOYSA-N 0.000 claims 1
- 239000004144 Ethoxylated Mono- and Di-Glyceride Substances 0.000 claims 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000000728 ammonium alginate Substances 0.000 claims 1
- 239000006229 carbon black Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 238000003825 pressing Methods 0.000 claims 1
- 239000000473 propyl gallate Substances 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims 1
- 229910001948 sodium oxide Inorganic materials 0.000 claims 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 3
- 125000006239 protecting group Chemical group 0.000 abstract 2
- QITDACOZCQXYQY-BAFYGKSASA-N (6r)-7-amino-5-thia-1-azabicyclo[4.2.0]oct-2-en-8-one Chemical class S1CC=CN2C(=O)C(N)[C@H]21 QITDACOZCQXYQY-BAFYGKSASA-N 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 238000007327 hydrogenolysis reaction Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- QPHZWABVAIGWHI-UHFFFAOYSA-N 3-methyl-2h-1,2,4-thiadiazole-5-thione Chemical compound CC1=NSC(S)=N1 QPHZWABVAIGWHI-UHFFFAOYSA-N 0.000 description 1
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 102000010410 Nogo Proteins Human genes 0.000 description 1
- 108010077641 Nogo Proteins Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- OXDRBKKGZFUHSW-UHFFFAOYSA-M [Na+].CON=C(C([O-])=O)C1=CSC(NC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 Chemical compound [Na+].CON=C(C([O-])=O)C1=CSC(NC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 OXDRBKKGZFUHSW-UHFFFAOYSA-M 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- TVMUHOAONWHJBV-UHFFFAOYSA-N dehydroglycine Chemical compound OC(=O)C=N TVMUHOAONWHJBV-UHFFFAOYSA-N 0.000 description 1
- LFLBUCZDUUGSRC-UHFFFAOYSA-N ethyl 4-hydroxyimino-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)C=NO LFLBUCZDUUGSRC-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7704745A FR2381053A1 (fr) | 1977-02-18 | 1977-02-18 | Nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU841590A3 true SU841590A3 (ru) | 1981-06-23 |
Family
ID=9186946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU782578251A SU841590A3 (ru) | 1977-02-18 | 1978-02-14 | Способ получени производных - -( -АМиНО- -ТиАзОлил)- - АлКОКСииМиНОАцЕТАМидО - -( - ТиАдиАзОл- -илТиОМЕТил)цЕф- -EM-- КАРбОНОВОй КиСлОТы или иХ СОлЕйС щЕлОчНыМи МЕТАллАМи, B ВидЕ СиН-изО-MEPOB |
Country Status (23)
| Country | Link |
|---|---|
| JP (1) | JPS53108996A (enExample) |
| AT (1) | AT355722B (enExample) |
| AU (1) | AU516076B2 (enExample) |
| BE (1) | BE864074A (enExample) |
| CA (1) | CA1132537A (enExample) |
| CH (1) | CH633016A5 (enExample) |
| DE (1) | DE2806226A1 (enExample) |
| DK (1) | DK68978A (enExample) |
| ES (2) | ES467090A1 (enExample) |
| FI (1) | FI69468C (enExample) |
| FR (1) | FR2381053A1 (enExample) |
| GB (1) | GB1575180A (enExample) |
| GR (1) | GR71703B (enExample) |
| HU (1) | HU181961B (enExample) |
| IE (1) | IE46651B1 (enExample) |
| IL (1) | IL54043A (enExample) |
| LU (1) | LU79080A1 (enExample) |
| NL (1) | NL7801834A (enExample) |
| PT (1) | PT67673B (enExample) |
| SE (1) | SE434268B (enExample) |
| SU (1) | SU841590A3 (enExample) |
| YU (1) | YU41583B (enExample) |
| ZA (1) | ZA78847B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE878433A (fr) * | 1978-08-31 | 1980-02-25 | Fujisawa Pharmaceutical Co | Procede de preparation de derives d'acide 3-cephem-4-carboxylique 3,7-disubstitue, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne |
| BE878514A (fr) * | 1978-09-04 | 1980-02-29 | Fujisawa Pharmaceutical Co | Procede de preparation de composes d'acide 3-cephem-4-carboxylique a disubstitution en positions 3 et 7, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne |
| DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
| US4341775A (en) * | 1978-09-11 | 1982-07-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| DE2945248A1 (de) * | 1978-11-13 | 1980-05-22 | Fujisawa Pharmaceutical Co | Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel |
| CH642957A5 (de) | 1980-02-18 | 1984-05-15 | Lonza Ag | Verfahren zur herstellung von (2-aminothiazol-4-yl)-essigsaeure-hydrochlorid. |
| US4399132A (en) * | 1980-08-11 | 1983-08-16 | American Cyanamid Company | 7-Beta-[alpha-syn-methoxyimino-alpha-(2-aminothiazol-4-yl)-acetamido]-3-[(1,2,3-thiadiazol-5-ylthio)methyl]-3-cephem-4-carboxylic acid and C1 -C6 alkyl derivatives thereof |
| US4761409A (en) * | 1984-08-16 | 1988-08-02 | Sumitomo Pharmaceuticals Company, Limited | Cephem derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| DK162391C (da) * | 1976-04-12 | 1992-03-09 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser |
| DE2715385A1 (de) * | 1976-04-14 | 1977-11-10 | Takeda Chemical Industries Ltd | Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
-
1977
- 1977-02-18 FR FR7704745A patent/FR2381053A1/fr active Granted
-
1978
- 1978-01-23 SE SE7800790A patent/SE434268B/sv not_active IP Right Cessation
- 1978-02-10 FI FI780444A patent/FI69468C/fi not_active IP Right Cessation
- 1978-02-13 ZA ZA00780847A patent/ZA78847B/xx unknown
- 1978-02-13 IL IL54043A patent/IL54043A/xx unknown
- 1978-02-14 DE DE19782806226 patent/DE2806226A1/de not_active Withdrawn
- 1978-02-14 SU SU782578251A patent/SU841590A3/ru active
- 1978-02-14 YU YU336/78A patent/YU41583B/xx unknown
- 1978-02-16 DK DK68978A patent/DK68978A/da not_active Application Discontinuation
- 1978-02-16 GR GR55474A patent/GR71703B/el unknown
- 1978-02-17 JP JP1666578A patent/JPS53108996A/ja active Pending
- 1978-02-17 LU LU79080A patent/LU79080A1/xx unknown
- 1978-02-17 PT PT67673A patent/PT67673B/pt unknown
- 1978-02-17 CH CH178978A patent/CH633016A5/fr not_active IP Right Cessation
- 1978-02-17 AU AU33375/78A patent/AU516076B2/en not_active Expired
- 1978-02-17 ES ES467090A patent/ES467090A1/es not_active Expired
- 1978-02-17 CA CA297,248A patent/CA1132537A/fr not_active Expired
- 1978-02-17 BE BE185267A patent/BE864074A/xx not_active IP Right Cessation
- 1978-02-17 NL NL7801834A patent/NL7801834A/xx not_active Application Discontinuation
- 1978-02-17 HU HU78RO963A patent/HU181961B/hu unknown
- 1978-02-20 IE IE364/78A patent/IE46651B1/en unknown
- 1978-02-20 AT AT120978A patent/AT355722B/de not_active IP Right Cessation
- 1978-02-20 GB GB6621/78A patent/GB1575180A/en not_active Expired
- 1978-12-13 ES ES475956A patent/ES475956A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| LU79080A1 (fr) | 1978-09-28 |
| HU181961B (en) | 1983-11-28 |
| GR71703B (enExample) | 1983-06-21 |
| ES467090A1 (es) | 1979-06-01 |
| DK68978A (da) | 1978-08-19 |
| FR2381053B1 (enExample) | 1979-06-01 |
| SE434268B (sv) | 1984-07-16 |
| GB1575180A (en) | 1980-09-17 |
| CA1132537A (fr) | 1982-09-28 |
| PT67673A (fr) | 1978-03-01 |
| SE7800790L (sv) | 1978-08-19 |
| IL54043A0 (en) | 1978-04-30 |
| NL7801834A (nl) | 1978-08-22 |
| AU516076B2 (en) | 1981-05-14 |
| FI780444A7 (fi) | 1978-08-19 |
| AU3337578A (en) | 1979-08-23 |
| IL54043A (en) | 1983-02-23 |
| ATA120978A (de) | 1979-08-15 |
| ZA78847B (en) | 1979-03-28 |
| ES475956A1 (es) | 1979-12-16 |
| FR2381053A1 (fr) | 1978-09-15 |
| BE864074A (fr) | 1978-08-17 |
| CH633016A5 (en) | 1982-11-15 |
| FI69468B (fi) | 1985-10-31 |
| JPS53108996A (en) | 1978-09-22 |
| FI69468C (fi) | 1986-02-10 |
| YU41583B (en) | 1987-10-31 |
| AT355722B (de) | 1980-03-25 |
| YU33678A (en) | 1983-01-21 |
| IE46651B1 (en) | 1983-08-10 |
| DE2806226A1 (de) | 1978-08-24 |
| PT67673B (fr) | 1980-03-03 |
| IE780364L (en) | 1978-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6229436B2 (enExample) | ||
| CA1057283A (en) | 3-carbamoyloxymethyl-7-(2-(fur-2-yl)-2-methoxyiminoacetamido) ceph-3-em-4-carboxylic acid | |
| EP0175610A2 (en) | New cephalosporin compounds and the production thereof | |
| GB1580621A (en) | Oxime derivatives of 7-aminothiazolylacetamido-cephalosporanic acid processes for preparing them and pharmaceutical compositions incorporating them | |
| US20080207912A1 (en) | Method for manufacture of ceftiofur | |
| SU841590A3 (ru) | Способ получени производных - -( -АМиНО- -ТиАзОлил)- - АлКОКСииМиНОАцЕТАМидО - -( - ТиАдиАзОл- -илТиОМЕТил)цЕф- -EM-- КАРбОНОВОй КиСлОТы или иХ СОлЕйС щЕлОчНыМи МЕТАллАМи, B ВидЕ СиН-изО-MEPOB | |
| KR870001440B1 (ko) | 세팔로스포린 화합물의 제조방법 | |
| HU193158B (en) | Sposob poluchenija 3,7-dizamehhennykh proizvodnykh 3-cefem-4-karbonovykh kislot | |
| US4260607A (en) | Cephalosporin esters | |
| EP0392796A3 (en) | Cephalosporin derivatives | |
| HUT77700A (hu) | Eljárás cefotaxim előállítására | |
| JPH05132488A (ja) | 新規セフアロスポリン誘導体 | |
| JPH05255345A (ja) | 新規セファロスポリン誘導体 | |
| US4277601A (en) | Preparation of sodium cefuroxime | |
| CS219851B2 (en) | Method of making the crystallic hydrochloride or hydrobromide of the pivaloyloxymethylester 7beta-/2-/2-amino-4-thiazzolyl/-2-methoxyiminoacetamido/-3-cefem-4-carboxyle acid | |
| EP0142274A2 (en) | Cephalosporin compounds and salts thereof, their production, and medicaments containing them | |
| JPS5919114B2 (ja) | セフアロスポリンの製造法 | |
| KR0184861B1 (ko) | 세팔로스포린 유도체와 이의 제조방법 | |
| JPS58159497A (ja) | セフエム誘導体 | |
| JP2567799B2 (ja) | カルボキシアルケン酸及びその誘導体 | |
| GB2051066A (en) | Cephalosporin derivatives suitable for oral administration | |
| SU882412A3 (ru) | Способ получени производных 7-[2-(2-аминотиазол-4-ил)-2-метоксииминоацетамидо]-3-ацетоксиметил-3-цефем-4-карбоновой кислоты в виде син-изомеров | |
| JP2617618B2 (ja) | セフアロスポリン誘導体 | |
| EP0098615B1 (en) | 1-oxadethiacephalosporin compound and antibacterial agent containing the same | |
| EP0021688B1 (en) | 7-(thiazolylpropionamido) cephalosporins, their preparation, and pharmaceutical compositions containing them |